Literature DB >> 12543738

Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.

B D Gaynor1, K A Holbrook, J P Whitcher, S O Holm, H C Jha, J S P Chaudhary, R C Bhatta, T Lietman.   

Abstract

AIMS: To determine if macrolide resistant Streptococcus pneumoniae will be a major concern in areas that receive annual mass azithromycin distributions for trachoma.
METHODS: A cross sectional survey was conducted of nasopharyngeal S pneumoniae isolates for susceptibility to azithromycin 1 year after administering a single dose of azithromycin to treat trachoma in a village in Nepal.
RESULTS: S pneumoniae was isolated from 50 (86%) of 57 nasopharyngeal cultures and no resistance to azithromycin was detected.
CONCLUSION: The authors were unable to demonstrate that mass azithromycin therapy for trachoma produced macrolide resistant S pneumoniae that persists until the next scheduled annual treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543738      PMCID: PMC1771508          DOI: 10.1136/bjo.87.2.147

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal.

Authors:  S O Holm; H C Jha; R C Bhatta; J S Chaudhary; B B Thapa; D Davis; R P Pokhrel; M Yinghui; M Zegans; J Schachter; K D Frick; L Tapert; T M Lietman
Journal:  Bull World Health Organ       Date:  2003-07-07       Impact factor: 9.408

2.  Global elimination of trachoma: how frequently should we administer mass chemotherapy?

Authors:  T Lietman; T Porco; C Dawson; S Blower
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

Authors:  C Thornsberry; M E Jones; M L Hickey; Y Mauriz; J Kahn; D F Sahm
Journal:  J Antimicrob Chemother       Date:  1999-12       Impact factor: 5.790

4.  Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

Authors:  G V Doern; M A Pfaller; K Kugler; J Freeman; R N Jones
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

5.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Authors:  H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

6.  A targeted, single-dose azithromycin strategy for trachoma.

Authors:  A C Laming; B J Currie; M DiFrancesco; H R Taylor; J D Mathews
Journal:  Med J Aust       Date:  2000-02-21       Impact factor: 7.738

7.  A simple system for the assessment of trachoma and its complications.

Authors:  B Thylefors; C R Dawson; B R Jones; S K West; H R Taylor
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

8.  A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.

Authors:  A J Leach; T M Shelby-James; M Mayo; M Gratten; A C Laming; B J Currie; J D Mathews
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

9.  Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

Authors:  R L Bailey; P Arullendran; H C Whittle; D C Mabey
Journal:  Lancet       Date:  1993-08-21       Impact factor: 79.321

10.  Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study.

Authors:  K F Tabbara; A Abu-el-Asrar; O al-Omar; A H Choudhury; Z al-Faisal
Journal:  Ophthalmology       Date:  1996-05       Impact factor: 12.079

View more
  18 in total

1.  Topical ocular antibiotics induce bacterial resistance at extraocular sites.

Authors:  B D Gaynor; J D Chidambaram; V Cevallos; Y Miao; K Miller; H C Jha; R C Bhatta; J S P Chaudhary; S Osaki Holm; J P Whitcher; K A Holbrook; A M Fry; T M Lietman
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 2.  Ocular Chlamydia trachomatis infection: elimination with mass drug administration.

Authors:  Meraf A Wolle; Sheila K West
Journal:  Expert Rev Anti Infect Ther       Date:  2019-02-18       Impact factor: 5.091

3.  Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children.

Authors:  Christian L Coles; Jessica C Seidman; Joshua Levens; Harran Mkocha; Beatriz Munoz; Sheila West
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

4.  Impact of intermittent preventive treatment in pregnancy with azithromycin-containing regimens on maternal nasopharyngeal carriage and antibiotic sensitivity of Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus: a cross-sectional survey at delivery.

Authors:  Holger W Unger; Celestine Aho; Maria Ome-Kaius; Regina A Wangnapi; Alexandra J Umbers; Wanda Jack; Alice Lafana; Audrey Michael; Sarah Hanieh; Peter Siba; Ivo Mueller; Andrew R Greenhill; Stephen J Rogerson
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

5.  Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.

Authors:  Alison H Skalet; Vicky Cevallos; Berhan Ayele; Teshome Gebre; Zhaoxia Zhou; James H Jorgensen; Mulat Zerihun; Dereje Habte; Yared Assefa; Paul M Emerson; Bruce D Gaynor; Travis C Porco; Thomas M Lietman; Jeremy D Keenan
Journal:  PLoS Med       Date:  2010-12-14       Impact factor: 11.069

Review 6.  Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.

Authors:  R Matthew Chico; Daniel Chandramohan
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-07-07       Impact factor: 4.481

7.  Antibiotics for trachoma.

Authors:  Jennifer R Evans; Anthony W Solomon; Rahul Kumar; Ángela Perez; Balendra P Singh; Rajat Mohan Srivastava; Emma Harding-Esch
Journal:  Cochrane Database Syst Rev       Date:  2019-09-26

Review 8.  Epidemiology and control of trachoma: systematic review.

Authors:  Victor H Hu; Emma M Harding-Esch; Matthew J Burton; Robin L Bailey; Julbert Kadimpeul; David C W Mabey
Journal:  Trop Med Int Health       Date:  2010-04-04       Impact factor: 2.622

Review 9.  Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.

Authors:  R Matthew Chico; Rudiger Pittrof; Brian Greenwood; Daniel Chandramohan
Journal:  Malar J       Date:  2008-12-16       Impact factor: 2.979

10.  Azithromycin, fluoroquinolone and chloramphenicol resistance of non-chlamydia conjunctival bacteria in rural community of Ethiopia.

Authors:  Bayeh Abera; Mulugeta Kibret
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.